4 ms·
Seems weird to do a Phase I trial in healthy volunteers for a monoclonal antibody targeted to Parkinson's.
by sjg007 11y ago
Seems weird to do a Phase I trial in healthy volunteers for a monoclonal antibody targeted to Parkinson's.
- sp332 11y agoPhase I is for safety. And it's hard to separate the effects of the drug from other health effects if the patients aren't healthy to begin with.
- chrisseaton 11y agoThis is the whole point of a Phase 1 trial. https://en.wikipedia.org/wiki/Phases_of_clinical_research#Phase_I https://en.wikipedia.org/wiki/Phases_of_clinical_research#Ph...
- sjg007 11y agoYou don't test Phase 1 anticancer drugs in healthy volunteers. So likewise monoclonal antibodies for Parkinson's should probably be first tested in the affected population. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678815/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678815/
- intrasight 11y agoPerhaps they do - if all Phase 1 is done on healthy human guinea pigs. Better question is why do we allow otherwise healthy people to be guinea pigs?
- Fomite 11y agoBecause we need to know about drug side effects, and it's extremely difficult, if not impossible, to parse out those effects in people who are already very sick. Additionally, those side effects are likely far less dangerous in an otherwise healthy individual.
- cjbprime 11y ago> You don't test Phase 1 anticancer drugs in healthy volunteers. [citation needed]
- ig1 11y agoOnly when they're known to be toxic, drugs which are considered otherwise benign (or at least not excessively toxic) which include some newer cancer drugs are tested in healthy volunteers.